Common knowledge used to hold that men over the age of 50 needed to get an annual digital prostate exam. Catching cancer early is important, but do men really need to get the uncomfortable procedure ...

PORTLAND, Ore. -- Biopsies detect prostate cancer in about one-fourth of men with abnormal screening tests. However, a negative biopsy does not ensure the absence of disease. Repeat prostate biopsies ...

Holmium laser enucleation of the prostate (HoLEP) is a procedure where a doctor uses a laser to remove prostate tissue from an enlarged prostate that’s restricting urine flow. Benign prostatic ...

September is Prostate Cancer Awareness Month. Prostate cancer affects one in six men in the U.S. Urologists recommend men between the ages of 50 and 75 get a prostate screening, which includes a ...

Imagine you are a patient who is undergoing abdominal surgery, perhaps you have a gynecological or prostate issue. Naturally you gravitate to the best hospital in your network or you follow your ...

The prostate gland, though small, plays a crucial role in men’s health. Located below the bladder, this walnut-sized organ often goes unnoticed until problems arise. Medical experts emphasize that ...

AWARENESS MONTH, AND ACCORDING TO THE AMERICAN CANCER SOCIETY, THE DISEASE SEES OVER 300,000 NEW CASES YEARLY, AS WELL AS MORE THAN 35,000 DEATHS A YEAR, MAKING IT CRUCIAL FOR MEN TO UNDERGO A ...

According to the National Institutes of Health, as many as 14 million men in the United States have symptoms of benign prostatic hyperplasia, or an enlarged prostate. American Cancer Society ...

Editor’s Note: This piece was submitted by a contributing writer and does not represent the views of CURE Media Group. If I could have blown a whistle and called a foul in the doctor's office, I might ...

Prostate health remains a crucial topic that many men avoid discussing, even with close family members. Early screenings can make a significant difference in detecting issues before they become severe ...

MDxHealth has 4 validated testing products with one more in the clinical pipeline. All are focused specifically on urology. The company expects to do ~$65-$70M of sales in 2023, but the valuation is a ...